Curtis Charles Schultz, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Pinson Blvd, Pinson, AL 35126 Phone: 205-680-2751 |
Joshua C Hardin, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6662 Highway 75, Suite 118, Pinson, AL 35126 Phone: 205-680-3737 Fax: 205-680-3784 |
Dana N Johnson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4701 Center Point Rd, Pinson, AL 35126 Phone: 205-680-3969 Fax: 205-680-0935 |
Mr. Robert Douglas Raffield Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4701 Center Point Rd, Pinson, AL 35126 Phone: 205-680-3969 |
Dr. Daniel Lee Parkins, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Center Point Rd, Pinson, AL 35126 Phone: 205-680-2751 |
Dr. Rebecca A Traywick, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5150 Old Springville Rd, Pinson, AL 35126 Phone: 205-815-5373 |
Murshiva Harris Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6665 Highway 75, Pinson, AL 35126 Phone: 205-681-9250 |
Dr. Michael S Oniszko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4701 Center Point Rd, Pinson, AL 35126 Phone: 205-680-3969 Fax: 205-680-0935 |
Mr. Darren Wayne Ingram, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Center Point Rd, Pinson, AL 35126 Phone: 205-680-2751 Fax: 205-680-6751 |
Shannon Mattox Hurst, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4679 Center Point Road, Pinson, AL 35126 Phone: 206-680-2751 Fax: 205-680-6751 |
Erin Gardner Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Pinson Blvd, Pinson, AL 35126 Phone: 205-680-2751 |
Dr. Katherine Trippe, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4701 Center Point Rd, Pinson, AL 35126 Phone: 205-680-3969 Fax: 205-680-0935 |
Johnathon Barnett Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Center Point Rd, Pinson, AL 35126 Phone: 205-680-2751 |
Saige Evans Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8690 Pine Mountain Rd, Pinson, AL 35126 Phone: 239-280-8888 |
Mr. Jon E Seeley, BS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5842 Sumpter Dr, Pinson, AL 35126 Phone: 205-323-4548 Fax: 205-521-6854 |
Chase Lash Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Center Point Rd, Pinson, AL 35126 Phone: 205-680-2751 |
Mr. Charles Milton Henckell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5150 Old Springville Rd, Pinson, AL 35126 Phone: 205-815-5373 Fax: 205-815-5534 |
Dr. Manisha Modi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6665 Highway 75, Pinson, AL 35126 Phone: 205-681-9250 |
Shannon Gallaspy Walker, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5150 Old Springville Rd, Pinson, AL 35126 Phone: 205-815-5373 Fax: 205-815-5524 |
Dr. Jade Lasseigne Sullivan, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4689 Center Point Rd, Pinson, AL 35126 Phone: 205-680-2751 Fax: 205-680-6751 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.
In 2005, the Food and Drug Administration approved a drug called BiDil as a therapy for heart failure specifically for African-American patients, claiming in a press release that this was a step toward personalized medicine.
A recent US study showed that in order to prevent or largely extinguish the coronavirus disease 2019 (COVID-19) outbreak without social distancing or any other measures, any vaccine would have to have an efficacy of at least 70%. The research paper is currently available on the medRxiv* preprint server.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
Women were less likely than men to receive major funding for scientific research, according to a study from the University of Michigan Health System. The study also found that only a quarter of all researchers, both men and women, who received a major early career award went on to get further federal funding within five years.
› Verified 4 days ago